Springer Nature

sorry, we can't preview this file

...but you can still download 13148_2019_681_MOESM2_ESM.tif
13148_2019_681_MOESM2_ESM.tif (680.24 kB)

Additional file 2: of Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras status

Download (680.24 kB)
posted on 2019-05-29, 05:00 authored by Min-Wu Chao, Li-Hsun Chang, Huang-Ju Tu, Chao-Di Chang, Mei-Jung Lai, Yi-Ying Chen, Jing-Ping Liou, Che-Ming Teng, Shiow-Lin Pan
Figure S2. MEK inhibitors downregulate HDAC inhibitor-induced p-ERK and EGFR expression. (A) PANC-1 cells were treated with 5 μM MPT0E028 or SAHA combined with or without 20 μM PD98059 (PD) for 72 h. The protein expression of p-ERK and EGFR was determined by western blotting. t-ERK was used as an internal control. PANC-1 (B) and BxPC-3 (C) cells were treated with indicated conditions for 48 h to determine EGFR mRNA expression. *P < 0.05, **P < 0.005, and ****P < 0.0001 compared with the indicated group. (TIF 680 kb)


Ministry of Science and Technology of Taiwan